The interface of perinatal HIV prevention, antiretroviral drug resistance, and antiretroviral treatment - What so we really know?

被引:14
作者
Fowler, MG [1 ]
Mofenson, L
McConnell, M
机构
[1] Ctr Dis Control & Prevent, Epidemiol Branch, Div HIV AIDS Prevent, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Global Programme AIDS, Prevent Branch, Atlanta, GA USA
[3] NICHHD, Ctr Res Mothers & Children, Pediat Adolescent & Maternal AIDS Branch, Rockville, MD USA
关键词
D O I
10.1097/00126334-200311010-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:308 / 311
页数:4
相关论文
共 37 条
[1]   Zidovudine resistance phenotype and risk of perinatal HIV-1 transmission in zidovudine monotherapy-treated mothers with moderately advanced disease [J].
Bauer, GR ;
Welles, SL ;
Colgrove, RR ;
Pitt, J .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (03) :312-319
[2]   Sex differences in nevirapine rash [J].
Bersoff-Matcha, SJ ;
Miller, WC ;
Aberg, JA ;
van der Horst, C ;
Hamrick, HJ ;
Powderly, WG ;
Mundy, LM .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) :124-129
[3]  
*BOEHR ING PHARM, 2003, VIR DRUG LAB
[4]   Extent and importance of cross-resistance to efavirenz after nevirapine failure [J].
Casado, JL ;
Moreno, A ;
Hertogs, K ;
Dronda, F ;
Moreno, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (11) :771-775
[5]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1
[6]  
CHAOWANACHAN T, 2003, 10 C RETR OPP INF BO
[7]   Selective vertical transmission of HIV-1 antiretroviral resistance mutations [J].
Colgrove, RC ;
Pitt, J ;
Chung, PH ;
Welles, SL ;
Japour, AJ .
AIDS, 1998, 12 (17) :2281-2288
[8]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[9]  
Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009
[10]   Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: A substudy of Pediatric AIDS Clinical Trials Group protocol 316 [J].
Cunningham, CK ;
Chaix, ML ;
Rekacewicz, C ;
Britto, P ;
Rouzioux, C ;
Gelber, RD ;
Dorenbaum, A ;
Delfraissy, JF ;
Bazin, B ;
Mofenson, L ;
Sullivan, JL .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (02) :181-188